These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 1548520)
21. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M; Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206 [TBL] [Abstract][Full Text] [Related]
22. Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy? Kuo LJ; Liu MC; Jian JJ; Horng CF; Cheng TI; Chen CM; Fang WT; Chung YL Ann Surg Oncol; 2007 Oct; 14(10):2766-72. PubMed ID: 17551794 [TBL] [Abstract][Full Text] [Related]
23. Combination chemotherapy containing semustine (MeCCNU) in patients with advanced colorectal cancer previously treated with 5-fluorouracil (5-Fu). Engstrom PF; MacIntyre JM; Douglass HO; Muggia F; Mittelman A Am J Clin Oncol; 1983 Apr; 6(2):175-80. PubMed ID: 6829492 [TBL] [Abstract][Full Text] [Related]
24. Postoperative adjuvant 5-fluorouracil plus methyl-CCNU therapy for gastric cancer patients. Eastern Cooperative Oncology Group study (EST 3275). Engstrom PF; Lavin PT; Douglass HO; Brunner KW Cancer; 1985 May; 55(9):1868-73. PubMed ID: 3884131 [TBL] [Abstract][Full Text] [Related]
25. Randomised clinical trial of adjuvant postoperative RT vs. sequential postoperative RT plus 5-FU and levamisole in patients with stage II-III resectable rectal cancer: a final report. Cafiero F; Gipponi M; Lionetto R; J Surg Oncol; 2003 Jul; 83(3):140-6. PubMed ID: 12827681 [TBL] [Abstract][Full Text] [Related]
26. Mitomycin-C/5-fluorouracil/leucovorin and hyperfractionated radiation therapy for rectal carcinoma: a phase II study with long-term follow-up. Nabhan C; Ragam A; Samuels B; Milton DT; Prasad L; Hooberman A; Hartsell W; Anthony A; Weisman R; Bitran JD Clin Colorectal Cancer; 2007 Mar; 6(6):436-41. PubMed ID: 17531107 [TBL] [Abstract][Full Text] [Related]
27. [Developments up to now and current status of adjuvant chemo- and radiotherapy in colonic and rectal carcinoma]. Kraus TW; Eble MJ; Raeth U Langenbecks Arch Chir; 1994; 379(6):353-7. PubMed ID: 7845161 [TBL] [Abstract][Full Text] [Related]
28. Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04). Mamounas E; Wieand S; Wolmark N; Bear HD; Atkins JN; Song K; Jones J; Rockette H J Clin Oncol; 1999 May; 17(5):1349-55. PubMed ID: 10334518 [TBL] [Abstract][Full Text] [Related]
29. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. Fisher B; Wolmark N; Rockette H; Redmond C; Deutsch M; Wickerham DL; Fisher ER; Caplan R; Jones J; Lerner H J Natl Cancer Inst; 1988 Mar; 80(1):21-9. PubMed ID: 3276900 [TBL] [Abstract][Full Text] [Related]
30. A Phase I trial of preoperative eniluracil plus 5-fluorouracil and radiation for locally advanced or unresectable adenocarcinoma of the rectum and colon. Czito BG; Hong TJ; Cohen DP; Tyler DS; Lee CG; Anscher MS; Ludwig KA; Seigler HF; Mantyh C; Morse MA; Lockhart AC; Petros WP; Honeycutt W; Spector NL; Ertel PJ; Mangum SG; Hurwitz HI Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):779-85. PubMed ID: 14967434 [TBL] [Abstract][Full Text] [Related]
31. Efficacy of postoperative 5-FU, high-dose leucovorin, and sequential radiation therapy for clinically resectable rectal cancer. Minsky BD; Cohen AM; Enker WE; Kelsen DP; Kemeny N; Frankel J Cancer Invest; 1995; 13(1):1-7. PubMed ID: 7834464 [TBL] [Abstract][Full Text] [Related]
32. Clinical experience with chronomodulated infusional 5-fluorouracil chemoradiotherapy for pancreatic adenocarcinoma. Keene KS; Rich TA; Penberthy DR; Shepard RC; Adams R; Jones RS Int J Radiat Oncol Biol Phys; 2005 May; 62(1):97-103. PubMed ID: 15850908 [TBL] [Abstract][Full Text] [Related]
33. Five-year results of a randomized controlled trial of adjuvant chemotherapy for curatively resected colorectal carcinoma. The Colorectal Cancer Chemotherapy Study Group of Japan. Jpn J Clin Oncol; 1995 Jun; 25(3):91-103. PubMed ID: 7596054 [TBL] [Abstract][Full Text] [Related]
34. Chemotherapy of advanced colorectal carcinoma: fluorouracil alone vs. two drug combinations using fluorouracil, hydroxyurea, semustine, dacarbazine, razoxane, and mitomycin. A phase III trial by the Eastern Cooperative Oncology Group (EST: 1278). Engstrom PF; MacIntyre JM; Mittelman A; Klaassen DJ Am J Clin Oncol; 1984 Aug; 7(4):313-8. PubMed ID: 6377866 [TBL] [Abstract][Full Text] [Related]
35. Chemotherapy of advanced measurable colon and rectal carcinoma with oral 5-fluorouracil, alone or in combination with cyclophosphamide or 6-thioguanine, with intravenous 5-fluorouracil or beta-2'-deoxythioguanosine or with oral 3(4-methyl-cyclohexyl)-1(2-chlorethyl)-1-nitrosourea: a Phase II-III study of the Eastern Cooperative Oncology Group (EST 4273). Douglass HO; Lavin PT; Woll J; Conroy JF; Carbone P Cancer; 1978 Dec; 42(6):2538-45. PubMed ID: 365312 [TBL] [Abstract][Full Text] [Related]
36. Early evaluation of combined fluorouracil and leucovorin as a radiation enhancer for locally unresectable, residual, or recurrent gastrointestinal carcinoma. The North Central Cancer Treatment Group. Moertel CG; Gunderson LL; Mailliard JA; McKenna PJ; Martenson JA; Burch PA; Cha SS J Clin Oncol; 1994 Jan; 12(1):21-7. PubMed ID: 8270979 [TBL] [Abstract][Full Text] [Related]
38. Comparison of 5-fluorouracil alone, 5-fluorouracil with levamisole, and 5-fluorouracil with hepatic irradiation in the treatment of patients with residual, nonmeasurable, intra-abdominal metastasis after undergoing resection for colorectal carcinoma. Witte RS; Cnaan A; Mansour EG; Barylak E; Harris JE; Schutt AJ Cancer; 2001 Mar; 91(5):1020-8. PubMed ID: 11251955 [TBL] [Abstract][Full Text] [Related]